Seroprevalence of SARS-CoV-2 in a Fully Operative Dentistry Academic Center in Madrid (Spain) During the De-escalation Phase of the COVID-19 Pandemic. Are Our Dentists at Greater Risk?

Oral Health Prev Dent. 2022 Oct 19;20(1):349-353. doi: 10.3290/j.ohpd.b3464887.

Abstract

Purpose: To determine the prevalence of COVID-19 infection among dental professionals at an Academic Center in Madrid (Spain) at the beginning of the pandemic's de-escalation phase.

Materials and methods: A cross-sectional study was designed. COVID-19 infection was determined by membrane-based immunoassay qualitative detection of IgG and IgM antibodies in human whole blood. Age, sex, race and professional qualification were recorded, as were symptoms compatible with COVID-19 infection whenever present. Data collected were analysed by means of descriptive and qualitative (X2) statistical analyses.

Results: A total of 195 individuals were included (40 administrative professionals and 155 dentists). Seroprevalence at the end of the de-escalation phase was 20.0% among all the participants. The highest prevalence was found among the orthodontists (34.8%), followed by the paediatric dentists (28.6%) and oral surgeons (14.7%). Most subjects were positive for IgG and negative for IgM (79.5%).

Conclusions: The seroprevalence of SARS-CoV-2 among dental professionals at the end of the de-escalation phase after the first wave of the pandemic was almost double the seroprevalence of the general population. Orthodontists had the highest rates of SARS-CoV-2 infection.

Keywords: COVID-19; antibodies; dental clinics; orthodontics.; seroprevalence.

MeSH terms

  • COVID-19* / epidemiology
  • Child
  • Cross-Sectional Studies
  • Dentistry, Operative
  • Dentists
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Pandemics
  • SARS-CoV-2*
  • Seroepidemiologic Studies
  • Spain / epidemiology

Substances

  • Immunoglobulin M
  • Immunoglobulin G